| Literature DB >> 35457784 |
Young-Sang Kim1,2, Hyun-Joo An3,4, Jaeseong Kim5, You-Jin Jeon1,2.
Abstract
Among marine biotoxins, palytoxins (PlTXs) and cyclic imines (CIs), including spirolides, pinnatoxins, pteriatoxins, and gymnodimines, are not managed in many countries, such as the USA, European nations, and South Korea, because there are not enough poisoning cases or data for the limits on these biotoxins. In this article, we review unregulated marine biotoxins (e.g., PlTXs and CIs), their toxicity, causative phytoplankton species, and toxin extraction and detection protocols. Due to global warming, the habitat of the causative phytoplankton has expanded to the Asia-Pacific region. When ingested by humans, shellfish that accumulated toxins can cause various symptoms (muscle pain or diarrhea) and even death. There are no systematic reports on the occurrence of these toxins; however, it is important to continuously monitor causative phytoplankton and poisoning of accumulating shellfish by PlTXs and CI toxins because of the high risk of toxicity in human consumers.Entities:
Keywords: cyclic imine; harmful algal bloom; marine biotoxin; palytoxin
Mesh:
Substances:
Year: 2022 PMID: 35457784 PMCID: PMC9026528 DOI: 10.3390/ijerph19084921
Source DB: PubMed Journal: Int J Environ Res Public Health ISSN: 1660-4601 Impact factor: 4.614
Figure 1Fish and seafood consumption per capita, 2017. Data based on per capita food supply at the consumer level but food wastage at the consumer level is not considered. (Source: UN Food and Agriculture Organization).
Figure 2Observed temperature changes over the 1850–2018 period. Following the preindustrial period (1850–1900), the observed mean land surface air temperature has risen considerably in comparison with the global mean surface (land and ocean) temperature.
Classification of marine biotoxins and the key adverse effects in humans.
| Type of | Marine Biotoxins | Source | Symptomatology |
|---|---|---|---|
| PSP | Saxitoxin | Gastrointestinal symptoms | |
| ASP | Domoic acid | Gastrointestinal and neurological symptoms | |
| DSP | Okadaic acid | Gastrointestinal symptoms | |
| Dinophysistoxins |
| nausea, vomiting, severe diarrhea | |
| NSP | Brevetoxin |
| Gastrointestinal and neurological symptoms, |
| AZA | Azaspiracid |
| Gastrointestinal symptoms |
| YTX | Yessotoxins |
| Lack of observations in humans |
| CFP | Ciguatoxin | Gastrointestinal symptoms, | |
| CIs | Spirolides | Lack of observations in humans | |
| Pinnatoxins |
| ||
| Pteriatoxins | |||
| Gymnodimines |
| ||
| PlTXs | Palytoxin |
| Gastrointestinal symptoms |
Figure 3Structure of the palytoxin isolated from the soft coral P. toxica.
Figure 4World distribution of toxic marine species. These species’ geographic ranges were retrieved from AlgaeBase.org and Aquamaps.org. These species create HABs, and their toxins accumulate in upper-food-web animals, such as fishes, shellfishes, and finally humans who consume these seafoods.
Cases of human poisoning through fishes containing PlTXs.
| Species | Localization | Toxins | References |
|---|---|---|---|
|
| Japan | Palytoxin-like toxins | [ |
|
| Japan | Palytoxin-like toxins | [ |
| Japan | Palytoxin-like toxins | [ | |
|
| Japan | Palytoxin | [ |
|
| Madagascar | Palytoxin and its analogue | [ |
Lethal doses of marine biotoxins.
| Toxins | Route | Lethal Dose | Refs. |
|---|---|---|---|
| Palytoxins | i.p. | i.p. injection into mice, LD50: − palytoxin: 50 ng/kg − ostreocin-D: 750 ng/kg − mascarenotoxin-A: 900 μg/kg | [ |
| Spirolides | i.p. | i.p. injection into mice, LD50: − spirolide A: 37 μg/kg − spirolide B: 99 μg/kg − spirolide C: 8 μg/kg − 13-desmethyl spirolide C: 7–28 μg/kg − 13,19-didesmethyl spirolide C: 32 μg/kg − 27-Hydroxy-13-desmethyl spirolide C: >27 μg/kg − 27-oxo-13,19-didesmethyl spirolide C: >35 μg/kg − spirolide E: >1000 μg/kg − spirolide F: >1000 μg/kg − 20-methyl spirolide G: 63 μg/kg | [ |
| Oral | Oral administration to mice, LD50 (μg/kg): − spirolide mixture (gavage): 1000 − spirolide C (gavage): 176 − spirolide C (fed on cream cheese): 780 | ||
| Pinnatoxins | i.p. | i.p. injection into mice, LD99 (μg/kg): − pinnatoxin A: 135–180 − pinnatoxin B and C: 22 − pinnatoxin D: 400 − pinnatoxin H: 67 − i.p. injection into mice, LD50 (μg/kg): − pinnatoxin E: 33.5–75.3 − pinnatoxin F: 9.5–15.8 − pinnatoxin G: 35.0–68.1 | [ |
| Oral | Oral administration to mice, LD50 (μg/kg): − pinnatoxin E (gavage): 2380–3000 − pinnatoxin F (gavage): 19.1–35.1 − pinnatoxin F (16 h fased): 37.9–71.5 − pinnatoxin G (gavage): 105–199 − pinnatoxin G (cream cheese mixture): 380–470 | ||
| Pteriatoxins | i.p. | i.p. injection into mice (LD99): − pteriatoxin A: 100 μg/kg − pteriatoxin B/C: 8 μg/kg | [ |
| Gymnodimines | i.p. | i.p. injection into mice, LD50 (μg/kg) − gymnodimine A: 79–118 − gymnodimine B: 800 | [ |
| Oral | Oral administration to mice LD50 (μg/kg): − gymnodimine A (gavage): 600–945 − gymnodimine A (voluntary feeding on mouse food): >7500 |
Figure 5Structures of CIs isolated from various phytoplankton species.
Methods for extraction, cleanup, and LC-based analysis of PlTXs and/or CIs from marine organisms.
| Sources | Target Toxins | Extraction | Clean up or Purification Process | Instruments | Column | Mobile Phase | Refs. |
|---|---|---|---|---|---|---|---|
|
| PlTX | 4 L of water below 10 °C | DEAE-cellulose column | Orbitrap Elite FT mass spectrometer | Reverse-phased column, Develosil C30-UG-3 2.0 i.d. ×100 mm | A: 0.1% acetic acid | [ |
| Mussel | PlTX | Methanol (MeOH)–H2O 8:2 ( | SPE (Strata-X, Strata-XL, OASIS HLB LP 6 cc, PolyLC INC) | LC-HRMS | 1. Gemini C18, 3 μm, 2 × 150 mm | A: H2O, 30 mM acetic acid | [ |
|
| PlTX | 50% EtOH | Charcoal | Gel filtration | 1. Sephadex G-S0 Column, 7 × 150 cm | 0.1 M acetic acid | [ |
| Gel filtration | 2. QAE-Sephadex A-25 Column, 3 × 30 cm | 0.01 M Tris-HCl, pH 8 | |||||
| Gel filtration | 3. SP-Sephadex column C-25, 1 × 60 cm | 0.01 M Na-acetate solution, pH 4.5 | |||||
| Ion exchange chromatography | 4. CM-Cellulose column, 1.5 × 30 cm | 0.005 M NH4-acetate buffer | |||||
| Gel filtration | 5. Biogel P-6 column (200–400 mesh) | 0.1 M acetic acid | |||||
|
| Ostreocin-D | MeOH followed by MeOH-H2O-AcOH (50:50:0.1) | Partitioning with CHCl3 and using aqueous part for further purification | Column chromatography | 1. Develosil Lop ODS column | MeOH-H2O-AcOH (90:10:0.2) | [ |
| 2. Develosil TMS-5 column | MeCN-H2O-AcOH from 22:78:0.1 (20 min) to 25:75:0.1 (30 min) | ||||||
| PlTXs | Water → homogenization → ultrasonication (320 W) | Add chloroform:MeOH (2:1) → separate aqueous layer (palytoxin) → SPE (1 mL C-18-T (Phenomenex, Torrance, CA, USA) | LC-MS/MS | 1. 50 × 2.1 mm Kinetex column (2.6 µm particle with C-18 from Phenomenex) | A: water (0.1% formic acid) | [ | |
| Ovatoxins a to e and isobaric PlTX | MeOH:water (1:1) → sonication for 10 min | - | LC-HRMS | Poroshell 120 EC-C18 (2.7 μm, 2.1 × 100 mm) column | A: water (30 mM acetic acid) | [ | |
| PlTX, ovatoxins a–d, mascarenotoxins a and c | MeOH:water (1:1) | 0.22 μm pore size membrane filter | LC/time-of-flight (TOF)-MS | Phenomenex Luna HILIC 3μ 150 × 2.00 mm | A: water (0.1% formic acid) | [ | |
| PlTX | 50% MeOH with sonication for 4 min | - | LC-HRMS | Accucore C18 column (2.6 μm, 100 × 2.1 mm; Thermo Fisher) | A: water (0.1% formic acid) | [ | |
| Isobaric PlTX, ovatoxins a–e, g | MeOH:water (80:20) | 0.22 μm syringe filter | hybrid linear ion trap LTQ | Poroshell 120 EC-C18, 2.7 μm, 100 × 2.10 mm column | A: water (30 mM acetic acid) | [ | |
| Greenshell mussel™ ( | PlTX | MeOH:water (1:1) | 60 mg Strata-X SPE cartridge (Phenomenex, Torrance, CA, USA) | LC-MS/MS | Acquity C18 HSS 1.7 μm column 50 × 1 mm | A: water (0.1% formic acid) | [ |
| Mediterranean mussels, European oysters, queen scallops, and ascidians | GYM, PnTX-G, SPX-C | MeOH | - | Electrospray ionization (ESI)-MS/MS | Zorbax SB-C8RRHD 2.1 × 50 mm, 1.8 μm | A: water (3.66 mM ammonium formate + 53 mM formic acid) | [ |
| Mussels ( | GYM-A, PnTX-G | MeOH | SPE, Strata-X cartridge, 30 mg/mL | LC-MS/MS | Agilent Zorbax SB-C8 Rapid Resolution HD (2.1 × 50 mm, 1.8 µm) | A: water (2 mM ammonium formate + 50 mM formic acid) | [ |
|
| GYM-B, SPX | MeOH | - | LC-MS/MS | 5 μm Poroshell C18, 50 × 2.1 mm Agilent column | A: water (2 mM ammonium formate) | [ |
| Shellfish | GYM-A, SPX | MeOH | LC-MS/MS (Thermo Ultimate 3000 HPLC system coupled to AB-Sciex Qtrap 4500 mass spectrometer) | Luna C18 column (50 mm × 2.1 mm Phenomenex) | A: water (2 mM ammonium formate + 50 mM formic acid) | [ | |
|
| GYM-A, SPX | MeOH | ESI-MS/MS | Thermo Finnegan BDS Hypersil C8 (50 mm × 2.1 mm, 3 μm) column | A: water (2 mM ammonium formate + 50 mM formic acid) | [ | |
| Waters X-Bridge C18 (150 mm × 3 mm, 5 μm) column | A: water (6.7 mM ammonium hydroxide) | ||||||
|
| 13-desmethyl SPX-C | 0.05% formic acid in MeOH | LC-MS | 50 × 2.1 mm i.d., 2.5 μm Luna C18 column (Phenomenex) | A: water (2 mM ammonium formate + 50 mM formic acid) | [ | |
| LC-HRMS | 2.7 μm Agilent Poroshell SB-C18 column | A: water (2 mM ammonium formate + 50 mM formic acid) | |||||
|
| 13-desmethyl SPX-C | MeOH | SPE cartridge (Waters Oasis HLB) | LC-HRMS | Poroshell 120 SB C18 column (2.1 × 150 mm, 2.7 μm) | A: water (2 mM ammonium formate + 50 mM formic acid) | [ |
| Shellfishes | CIs | MeOH | LC-MS/MS | Poroshell 120 EC-C18 column (100 × 2.1 mm, | A: 2 mM ammonium acetate and 18 mM glacial acetic acid in 5.2% methanol | [ | |
| 13-desmethyl SPX-C, PnTX-G | MeOH | UPLC-MS | Acquity UPLC BEH C18 (2.1 × 100 mm, 1.7 µm) | A: water (2 mM ammonium formate + 50 mM formic acid) | [ | ||
| Green mussels ( | 13-desMeC SPX, 20-Me SPX-G, GYM | MeOH | SPE | LC-MS/MS | 1.7 μm, 2.1 × 50 mm Acquity BEH Amide UPLC column | - | [ |
| 13-desMeC SPX, GYM-G, -H, -I, -J | MeOH | - | LC-HRMS | HyperClone BDS C8 column 50 × 2.0 mm, 13 Å, 3 μm | A: water (2 mM ammonium formate + 50 mM formic acid) | [ | |
| mussels | 13desmSPXC, GYMA, 13,19didesmSPXC, 20MethylSPXG and PnTXG | MeOH | 0.22 μm syringe filter | LC-MS/MS | Phenomenex Kinetex EVO C18 “core–shell” column 50 mm × 2.1 mm, 2.6 µm | A: water (6.7 mM NH4OH (pH 11)) | [ |